Soleno Therapeutics, Inc.
SLNO
$65.56
$2.824.50%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -1.07% | -0.51% | 13.50% | -3.51% | 77.86% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -49.38% | 139.19% | 72.31% | 3.19% | -13.60% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 2.55% | 5.11% | 13.82% | -3.48% | 76.89% |
|
|||||
Total Current Assets | 2.55% | 5.11% | 13.82% | -3.48% | 76.89% |
Net Property, Plant & Equipment | -6.34% | -6.97% | -6.40% | 1,010.80% | -21.37% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -7.69% | -7.16% | -6.67% | -6.25% | -5.88% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | -49.70% |
Total Assets | 4.47% | -3.89% | 11.55% | -2.44% | 80.13% |
|
|||||
Total Accounts Payable | 13.37% | -38.27% | 42.27% | 68.00% | -53.68% |
Total Accrued Expenses | 30.89% | -1.18% | 27.70% | 28.86% | 10.80% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 13.23% | 13.50% | 17.41% | 51.35% | -4.52% |
Total Finance Division Other Current Liabilities | 76.27% | 14.25% | -11.74% | 175.40% | -25.48% |
Total Other Current Liabilities | 76.27% | 14.25% | -11.74% | 175.40% | -25.48% |
Total Current Liabilities | 33.13% | -16.09% | 25.30% | 63.52% | -32.04% |
|
|||||
Total Current Liabilities | 33.13% | -16.09% | 25.30% | 63.52% | -32.04% |
Long-Term Debt | 0.02% | 0.02% | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -4.79% | -4.49% | -4.22% | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 6.85% | 20.87% | 2.41% | 1.69% | 19.03% |
Total Liabilities | 7.38% | -0.03% | 168.25% | 36.93% | -8.16% |
|
|||||
Common Stock & APIC | 1.75% | 4.46% | 5.59% | 9.91% | 36.09% |
Retained Earnings | -0.95% | -9.68% | -14.13% | -23.97% | -7.34% |
Treasury Stock & Other | -62.39% | -37.40% | -59.66% | 684.97% | -44.34% |
Total Common Equity | 3.39% | -5.24% | -7.40% | -5.72% | 95.81% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.39% | -5.24% | -7.40% | -5.72% | 95.81% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.39% | -5.24% | -7.40% | -5.72% | 95.81% |
|